P. vivax
Differential impact of malaria control interventions on P. falciparum and P. vivax infections in young Papua New Guinean children
13
A study on relapse/re infection rate of Plasmodium vivax malaria and identification of the predominant genotypes of P vivax in two endemic districts of Nepal
8
Modelling the global constraints of temperature on transmission of Plasmodium falciparum and P vivax
11
Naturally acquired humoral and cellular immune responses to Plasmodium vivax merozoite surface protein 8 in patients with P vivax infection
12
Differential patterns of infection and disease with P. falciparum and P. vivax in young Papua New Guinean children
15
Evidence for Diversifying Selection on Erythrocyte-Binding Antigens of Plasmodium falciparum and P. vivax
10
Comparison of clinical profile and severity of P. falciparum and P. vivax malaria in a tertiary care hospital of Surat, India
5
Evaluation of Plasmodium vivax Cell-Traversal Protein for Ookinetes and Sporozoites as a Preerythrocytic P. vivax Vaccine
14
Plasmodium falciparum, but not P vivax, can induce erythrocytic apoptosis
6
Molecular evidence of high rates of asymptomatic P vivax infection and very low P falciparum malaria in Botswana
8
Differential antibody responses to Plasmodium falciparum and P vivax circumsporozoite proteins in a human population
6
PCR/RFLP Based Analysis of Genetically Distinct Plasmodium vivax Population of Pvmsp 3α and Pvmsp 3β genes in Pakistan
7
Sequence conservation of Plasmodium vivax glutamate dehydrogenase among Korean isolates and its application in seroepidemiology
11
Prevalence of drug resistance associated mutations in Plasmodium vivax against sulphadoxine pyrimethamine in southern Pakistan
9
<p>Pharmacogene Variation in Thai <em>Plasmodium vivax</em> Relapse Patients Treated with a Combination of Primaquine and Chloroquine</p>
12
A Novel Erythrocyte Binding Protein of Plasmodium vivax Suggests an Alternate Invasion Pathway into Duffy Positive Reticulocytes
5
Chloroquine efficacy for Plasmodium vivax malaria treatment in southern Ethiopia
8
Monitoring the Response of Plasmodium vivax to Chloroquine and Uncomplicated P. falciparum to Artesunate-fansidar Anti-malarials in Southeastern Iran
8
Comparison of the safety and efficacy of fixed dose combination of arterolane maleate and piperaquine phosphate with chloroquine in acute, uncomplicated Plasmodium vivax malaria: a phase III, multicentric, open label study
13
Imported Plasmodium vivax malaria with severe thrombocytopaenia: can it be severe malaria or not?
9